News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
114last 24h
3131last 7d
511● bullish (7d)
314● bearish (7d)
227publishers
MarketBeat156d agoneutral
Assembly Biosciences Eyes Gilead HSV Plan as ABI-6250 Liver Pipeline ExpandsStocktwits157d agoneutral
Gilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026Simply Wall St.158d agoneutral
Assessing Gilead Sciences (GILD) Valuation After Recent Share Price WeaknessClinical Trials Arena158d agoneutral
Gilead eyes PBC expansion for Livdelzi on positive one-year dataSimply Wall St.159d agoneutral
How Investors Are Reacting To Gilead Sciences (GILD) Expanding Liver And Oncology Drug FootprintInsider Monkey159d agoneutral
Gilead Sciences (GILD) Announces New Results From a Post Hoc AnalysisInsider Monkey159d agoneutral
Gilead Sciences, Inc. (GILD) Gains Attention as Livdelzi Demonstrates Long-Term Efficacy and SafetyBarchart159d agoneutral
How Is Gilead Sciences's Stock Performance Compared to Other Healthcare StocksInsider Monkey159d agobullish
H.C. Wainwright Maintains Buy Rating on Tempus AI (TEM) Following Strong Revenue GrowthSimply Wall St.160d agoneutral
3 Stocks Estimated To Be Trading At Discounts Ranging From 24% To 49.9%Simply Wall St.160d agoneutral
Natera And 2 Other Companies That May Be Trading Below Their Estimated ValueSimply Wall St.163d agoneutral
Three Stocks That May Be Trading Below Estimated Value In May 2026Barrons.com164d agoneutral
S&P 500, Nasdaq Rise to Another Record. Software Strikes Back.Clinical Trials Arena164d agoneutral
FDA accelerated approval of Hepcludex significant milestone for US HDV marketSimply Wall St.166d agoneutral
3 Stocks Estimated To Be Trading Up To 44.8% Below Intrinsic ValueSimply Wall St.166d agoneutral
3 Stocks Estimated To Be Trading At Discounts Of Up To 44.1%BioPharma Dive166d agobearish
Astellas eyes more cost cuts; FDA panel to debate Moderna vaccineInsider Monkey167d agoneutral
Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology PortfolioSimply Wall St.167d agoneutral
Three Stocks That May Be Trading Below Their Estimated Value In May 2026Simply Wall St.167d agoneutral
May 2026's Top Stocks That Could Be Trading Below Estimated Fair Value